 |
| Pharmaceutical giants including GSK, Merck & Co, Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence to help streamline the drug discovery process |
The world's leading drug
companies are turning to artificial intelligence to improve the hit-and-miss
business of finding new medicines, with GlaxoSmithKline unveiling a new US$43
million deal in the field on Sunday.
